Deborah B Marin, MD
- PROFESSOR | Psychiatry
- ASSOCIATE PROFESSOR | Geriatrics and Palliative Medicine
Specialties:Psychiatry, Alzheimer's Disease, Geriatric Psychiatry
Dr. Marin attended The Mount Sinai School of Medicine and the Mount Sinai Psychiatry Residency. Upon completion of her Residency, Dr. Marin completed a research fellowship in mood disorders at Cornell Medical College. Since her return to Mount Sinai in 1992, Dr. Marin has held several leadership positions, including Chief of Geriatric Psychiatry, Medical Director of the Department of Psychiatry, Dean for Clinical Research, and Chief Medical Officer. At Mount Sinai, Dr. Marin’s research focus has been is in the area of memory disorders. She has been principal investigator in NIH funded grants that have investigated the clinical and biological correlates of normal aging and dementia. She has published several articles related to these topics. Dr. Marin’s clinical interests include the treatment of memory disorders and depression. Dr. Marin’s teaching interests are not only in the area of Psychiatry but also in the area of improving physician patient.
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
Psychiatry, American Board of Psychiatry and Neurology
MD, Mount Sinai Sch. of Medicine CUNY
Residency, Clinical Psychiatry, Mount Sinai Hospital
Fellowship, Clinical Psychiatry, Cornell University Medical College
Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis KL. Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Arch Neurol 2000; 57(8): 1145-1150.
Haroutunian V, Purohit DP, Perl DP, Marin D, Kahn K, Lantz M, Davis KL, Mohs RC. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 1999; 56(6): 713-718.
Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry 1999; 56(11): 981-987.
Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999; 28(15): 1401-1406.
Haroutunian V, Perl DP, Purohit DP, Marin D, Kahn K, Lantz M, Davis KL, Mohs RC. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 1998; 55(9): 1185-1191.
Marin DB, Breuer B, Marin ML, Silverman J, Schmeidler J, Greenberg D, Flynn S, Mare M, Lantz M, Libow L, Neufeld R, Altstiel L, Davis KL, Mohs RC. The relationship between alipoprotein E, dementia, and vascular illness. Atherosclerosis 1998; 140(1): 173-180.
Marin DB, Green CR, Schmeidler J, Harvey PD, Lawlor BA, Ryan TM, Aryan M, Davis KL, Mohs RC. Noncognitive disturbances in Alzheimer’s disease: frequency, longitudinal course, and relationship to cognitive symptoms. J Am Geriatr Soc 1997; 45(11): 1331-1338.
Davis KL, Marin DB, Kane R, Patrick D, Peskind ER, Raskind MA, Puder KL. The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer’s disease. International Journal of Geriatric Psychiatry 1997; 12(10): 978-988.
Altstiel LD, Greenberg DA, Marin D, Lantz M, Mohs R. Alipoprotein E genotype and cognition in the very old. The Lancet 1997; 349(9063): 1451.
Marin DB, Kocsis JH, Frances AJ, Parides M. Desipramine for the treatment of “pure” dysthymia versus “double” depression. The American Journal of Psychiatry 1994; 151(7): 1079-1080.